Prelude Capital Management’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-36,440
| Closed | -$106K | – | 1373 |
|
|
2024
Q2 | $106K | Sell |
36,440
-12,760
| -26% | -$37.3K | 0.01% | 999 |
|
|
2024
Q1 | $179K | Buy |
+49,200
| New | +$179K | 0.01% | 1020 |
|
|
2023
Q4 | – | Sell |
-32,932
| Closed | -$44.1K | – | 1136 |
|
|
2023
Q3 | $44.1K | Sell |
32,932
-32,572
| -50% | -$43.6K | ﹤0.01% | 910 |
|
|
2023
Q2 | $118K | Sell |
65,504
-8,271
| -11% | -$14.9K | 0.01% | 795 |
|
|
2023
Q1 | $122K | Sell |
73,775
-2,429
| -3% | -$4.03K | 0.01% | 837 |
|
|
2022
Q4 | $146K | Buy |
76,204
+23,500
| +45% | +$45.1K | 0.01% | 882 |
|
|
2022
Q3 | $118K | Buy |
+52,704
| New | +$118K | ﹤0.01% | 1116 |
|
|
2021
Q2 | – | Sell |
-12,762
| Closed | -$133K | – | 1541 |
|
|
2021
Q1 | $133K | Buy |
+12,762
| New | +$133K | ﹤0.01% | 978 |
|